T1D Prevention Using JAK Inhibitors

T1D Prevention Using JAK Inhibitors

Wednesday, July 14, 2021
8:00 AM - 9:00 AM

Presenter: Helen Thomas, PhD

Organization: St. Vincent Institute of Medical Research, Melbourne, Australia

Dr. Helen Thomas is head of the Immunology and Diabetes Unit at St. Vincent’s Institute in Melbourne. Her research is focused on prevention of type 1 diabetes. She aims to protect the insulin-producing cells in the pancreas from being destroyed by the immune system.

Her work is being applied to humans through the transplantation of human islets from organ donors to reverse diabetes and in a clinical trial to test the JAK inhibitor baricitinib in participants with newly-diagnosed type 1 diabetes. She collaborates with industry to test immune modulatory drugs in pre-clinical models for potential use in future clinical trials for type 1 diabetes.

Dr. Thomas strives to have a positive impact on the young scientists that she supervises and mentors.

Register now